Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Will TrovaGene Be an "ASCO Effect" Beneficiary?

Shares of TrovaGene Inc. (Nasdaq: TROV) surged more than 9% Friday and as much as 13.5% Monday after the Liquid Biopsy biotech company announced that a TrovaGene scientist presented clinical research findings at a prestigious cancer-treatment symposium in Florida.

With biotechs, these presentations can have an outsized impact on a company's share price.

  1. ulhas | May 19, 2016

    simply amazing predictions.

    • (Admin) Bill Patalon | May 20, 2016

      Dear Ulhas:

      Thanks for the kind words … and for taking the time to offer them.

      We've followed this opportunity closely.

      And we'll continue to do so.

      Thank you again. And I mean that.

      Respectfully yours;

      William Patalon III
      Editorial Director/Executive Editor
      Money Map Press LLC

Leave a Reply

Your email address will not be published. Required fields are marked *

Some HTML is OK